Latest filing published 28 May 2024 for Nexien Biopharma, INC..
Insider track record
No signal scores available.
Richard S. Greenberg: trading record in brief
All filings by Richard S. Greenberg on record concern Nexien Biopharma, Inc., in the capacity of chief executive. Over a trading history stretching from 28 June 2018 to 23 May 2024, the count stands at 12 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 28 May 2024 came the latest disclosure, a share grant in Nexien Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard S. Greenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 sharesCommon StockSEC:0001214659-24-010007:0
- 250,000 sharesCommon StockSEC:0001214659-23-014445:0
- 250,000 sharesCommon StockSEC:0001214659-23-010505:0
- 250,000 sharesCommon StockSEC:0001214659-23-005656:0
- 250,000 sharesCommon StockSEC:0001214659-23-000681:0
- 250,000 sharesCommon StockSEC:0001214659-22-012392:0
- 250,000 sharesCommon StockSEC:0001214659-22-011159:0
- 250,000 sharesCommon StockSEC:0001214659-22-001420:0
- 500,000 sharesCommon StockSEC:0001214659-21-012346:0
- 1,797,192 shares@ US$0.014Common StockSEC:0001214659-20-007471:0
- 1,800,880 shares@ US$0.014Common StockSEC:0001214659-20-007221:0
- 88,000 shares@ US$0.38Common StockSEC:0001214659-18-004709:0
12 of 12 declarations